Product Information
TOPIRAMATE ER 50 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $6.1331 per EA under NDC 68382086406. Its NADAC has been published 166 times since Jun 21, 2023.
FDA first approved this application on Nov 24, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382086406
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA207382FDA Approved
11/24/2017
TE Code
AB1
On Market Since
9/10/2024
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 50 MG CAPSULE has been published 166 times since Jun 21, 2023, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1331 per EA |
|---|---|
| All-time high | $12.4518 (Jul 12, 2023) |
| All-time low | $5.3769 (Nov 20, 2024) |
| 52-week high | $6.7514 |
| 52-week low | $5.7954 |
| Median price | $6.8919 |
| Average price | $7.4827 |
| Largest weekly change | -28.1% (Feb 21, 2024) |
| Weeks tracked | 166 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $6.1331 per EA (NDC 68382086406), effective Aug 19, 2026.
How has the price of TOPIRAMATE ER 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has declined 50.7%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG CAPSULE?
Since Jun 21, 2023, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has ranged from a low of $5.3769 (Nov 20, 2024) to a high of $12.4518 (Jul 12, 2023), with a median of $6.8919 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 50 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 50 MG SPRINKL CAP, is $3.3778 per EA — about 45% below TOPIRAMATE ER 50 MG CAPSULE.
Who manufactures TOPIRAMATE ER 50 MG CAPSULE?
TOPIRAMATE ER 50 MG CAPSULE (NDC 68382086406) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.